Renee Gaeta Sells 4,543 Shares of Outset Medical (NASDAQ:OM) Stock

Outset Medical, Inc. (NASDAQ:OM) CFO Renee Gaeta sold 4,543 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $4.39, for a total transaction of $19,943.77. Following the transaction, the chief financial officer directly owned 180,840 shares of the company’s stock, valued at $793,887.60. This represents a 2.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Renee Gaeta also recently made the following trade(s):

• On Wednesday, June 3rd, Renee Gaeta sold 17,672 shares of Outset Medical stock. The stock was sold at an average price of $4.94, for a total value of $87,299.68.

Outset Medical Stock Performance

Outset Medical stock opened at $4.30 on Thursday. The company has a quick ratio of 4.11, a current ratio of 5.19 and a debt-to-equity ratio of 1.03. The company has a market capitalization of $80.84 million, a P/E ratio of -1.05 and a beta of 1.96. The stock’s 50 day moving average is $4.57 and its 200 day moving average is $4.23. Outset Medical, Inc. has a twelve month low of $3.00 and a twelve month high of $16.16.

Outset Medical (NASDAQ:OM) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.80) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.72) by ($0.08). Outset Medical had a negative net margin of 63.06% and a negative return on equity of 61.67%. The company had revenue of $31.64 million for the quarter, compared to the consensus estimate of $28.97 million. On average, equities research analysts predict that Outset Medical, Inc. will post -3.8 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Outset Medical

Several institutional investors have recently modified their holdings of OM. Legal & General Group Plc bought a new stake in Outset Medical in the 2nd quarter worth about $34,000. BNP Paribas Financial Markets lifted its stake in Outset Medical by 7,013.8% during the 2nd quarter. BNP Paribas Financial Markets now owns 2,063 shares of the company’s stock valued at $40,000 after acquiring an additional 2,034 shares during the period. New York State Common Retirement Fund bought a new position in Outset Medical during the 2nd quarter valued at about $108,000. Los Angeles Capital Management LLC purchased a new stake in shares of Outset Medical during the 4th quarter valued at about $29,000. Finally, Quantbot Technologies LP purchased a new stake in shares of Outset Medical during the 2nd quarter valued at about $152,000.

Analysts Set New Price Targets

OM has been the topic of a number of analyst reports. TD Cowen reiterated a “buy” rating on shares of Outset Medical in a research note on Friday, May 8th. Wall Street Zen raised shares of Outset Medical from a “sell” rating to a “hold” rating in a report on Saturday, August 15th. Finally, Weiss Ratings upgraded shares of Outset Medical from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Outset Medical presently has an average rating of “Hold” and an average target price of $10.00.

Outset Medical Company Profile

Outset Medical is a medical technology company specializing in innovations for renal care. The company’s flagship offering, the Tablo Hemodialysis System, is designed to streamline and simplify dialysis treatment across acute and outpatient settings. By integrating water purification, dialysate production, and treatment monitoring into a single device, Tablo aims to reduce the complexity and logistical burden traditionally associated with hemodialysis therapy.

Tablo’s modular design allows for rapid setup and flexible deployment in hospitals, clinics, long‐term care facilities and emergency response scenarios.